Source: Investing.com ↗

Ondine Biomedical reports phase 3 trial meets primary endpoint

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,351.87

+1.13%

ETH/USDT

$2,750.73

+0.77%

ZEC/USDT

$1,625.15

+9.18%

XRP/USDT

$1.62

+6.59%